Volume 36, Issue 11, Page 39 (November 2008)
39 of 50
PREVIEW
FULL TEXT
FULL-TEXT PDF (112 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
NEED REPRINTS?
BOOKMARK ARTICLE
MUNICH — Smokers who struggle to quit during the standard 12-week course of varenicline derive particular benefit from a second 12-week stint on the drug, a large international clinical trial has shown.
PII: S0270-6644(08)70777-X
doi:10.1016/S0270-6644(08)70777-X
© 2008 Elsevier Inc. All rights reserved.
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
PREVIEW